Cargando…
Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol
INTRODUCTION: Cancer causes a substantial burden to our society, both from a health and an economic perspective. To improve cancer patient outcomes and lower society expenses, early diagnosis and timely treatment are essential. The recent COVID-19 crisis has disrupted the care trajectory of cancer p...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615261/ https://www.ncbi.nlm.nih.gov/pubmed/37903130 http://dx.doi.org/10.1371/journal.pone.0288777 |
_version_ | 1785129183442108416 |
---|---|
author | Khan, Yasmine Verhaeghe, Nick De Pauw, Robby Devleesschauwer, Brecht Gadeyne, Sylvie Gorasso, Vanessa Lievens, Yolande Speybroek, Niko Vandamme, Nancy Vandemaele, Miet Van den Borre, Laura Vandepitte, Sophie Vanthomme, Katrien Verdoodt, Freija De Smedt, Delphine |
author_facet | Khan, Yasmine Verhaeghe, Nick De Pauw, Robby Devleesschauwer, Brecht Gadeyne, Sylvie Gorasso, Vanessa Lievens, Yolande Speybroek, Niko Vandamme, Nancy Vandemaele, Miet Van den Borre, Laura Vandepitte, Sophie Vanthomme, Katrien Verdoodt, Freija De Smedt, Delphine |
author_sort | Khan, Yasmine |
collection | PubMed |
description | INTRODUCTION: Cancer causes a substantial burden to our society, both from a health and an economic perspective. To improve cancer patient outcomes and lower society expenses, early diagnosis and timely treatment are essential. The recent COVID-19 crisis has disrupted the care trajectory of cancer patients, which may affect their prognosis in a potentially negative way. The purpose of this paper is to present a flexible decision-analytic Markov model methodology allowing the evaluation of the impact of delayed cancer care caused by the COVID-19 pandemic in Belgium which can be used by researchers to respond to diverse research questions in a variety of disruptive events, contexts and settings. METHODS: A decision-analytic Markov model was developed for 4 selected cancer types (i.e. breast, colorectal, lung, and head and neck), comparing the estimated costs and quality-adjusted life year losses between the pre-COVID-19 situation and the COVID-19 pandemic in Belgium. Input parameters were derived from published studies (transition probabilities, utilities and indirect costs) and administrative databases (epidemiological data and direct medical costs). One-way and probabilistic sensitivity analyses are proposed to consider uncertainty in the input parameters and to assess the robustness of the model’s results. Scenario analyses are suggested to evaluate methodological and structural assumptions. DISCUSSION: The results that such decision-analytic Markov model can provide are of interest to decision makers because they help them to effectively allocate resources to improve the health outcomes of cancer patients and to reduce the costs of care for both patients and healthcare systems. Our study provides insights into methodological aspects of conducting a health economic evaluation of cancer care and COVID-19 including insights on cancer type selection, the elaboration of a Markov model, data inputs and analysis. |
format | Online Article Text |
id | pubmed-10615261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-106152612023-10-31 Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol Khan, Yasmine Verhaeghe, Nick De Pauw, Robby Devleesschauwer, Brecht Gadeyne, Sylvie Gorasso, Vanessa Lievens, Yolande Speybroek, Niko Vandamme, Nancy Vandemaele, Miet Van den Borre, Laura Vandepitte, Sophie Vanthomme, Katrien Verdoodt, Freija De Smedt, Delphine PLoS One Study Protocol INTRODUCTION: Cancer causes a substantial burden to our society, both from a health and an economic perspective. To improve cancer patient outcomes and lower society expenses, early diagnosis and timely treatment are essential. The recent COVID-19 crisis has disrupted the care trajectory of cancer patients, which may affect their prognosis in a potentially negative way. The purpose of this paper is to present a flexible decision-analytic Markov model methodology allowing the evaluation of the impact of delayed cancer care caused by the COVID-19 pandemic in Belgium which can be used by researchers to respond to diverse research questions in a variety of disruptive events, contexts and settings. METHODS: A decision-analytic Markov model was developed for 4 selected cancer types (i.e. breast, colorectal, lung, and head and neck), comparing the estimated costs and quality-adjusted life year losses between the pre-COVID-19 situation and the COVID-19 pandemic in Belgium. Input parameters were derived from published studies (transition probabilities, utilities and indirect costs) and administrative databases (epidemiological data and direct medical costs). One-way and probabilistic sensitivity analyses are proposed to consider uncertainty in the input parameters and to assess the robustness of the model’s results. Scenario analyses are suggested to evaluate methodological and structural assumptions. DISCUSSION: The results that such decision-analytic Markov model can provide are of interest to decision makers because they help them to effectively allocate resources to improve the health outcomes of cancer patients and to reduce the costs of care for both patients and healthcare systems. Our study provides insights into methodological aspects of conducting a health economic evaluation of cancer care and COVID-19 including insights on cancer type selection, the elaboration of a Markov model, data inputs and analysis. Public Library of Science 2023-10-30 /pmc/articles/PMC10615261/ /pubmed/37903130 http://dx.doi.org/10.1371/journal.pone.0288777 Text en © 2023 Khan et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Study Protocol Khan, Yasmine Verhaeghe, Nick De Pauw, Robby Devleesschauwer, Brecht Gadeyne, Sylvie Gorasso, Vanessa Lievens, Yolande Speybroek, Niko Vandamme, Nancy Vandemaele, Miet Van den Borre, Laura Vandepitte, Sophie Vanthomme, Katrien Verdoodt, Freija De Smedt, Delphine Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol |
title | Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol |
title_full | Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol |
title_fullStr | Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol |
title_full_unstemmed | Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol |
title_short | Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol |
title_sort | evaluating the health and health economic impact of the covid-19 pandemic on delayed cancer care in belgium: a markov model study protocol |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615261/ https://www.ncbi.nlm.nih.gov/pubmed/37903130 http://dx.doi.org/10.1371/journal.pone.0288777 |
work_keys_str_mv | AT khanyasmine evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol AT verhaeghenick evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol AT depauwrobby evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol AT devleesschauwerbrecht evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol AT gadeynesylvie evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol AT gorassovanessa evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol AT lievensyolande evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol AT speybroekniko evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol AT vandammenancy evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol AT vandemaelemiet evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol AT vandenborrelaura evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol AT vandepittesophie evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol AT vanthommekatrien evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol AT verdoodtfreija evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol AT desmedtdelphine evaluatingthehealthandhealtheconomicimpactofthecovid19pandemicondelayedcancercareinbelgiumamarkovmodelstudyprotocol |